U.S. federal trademark · Serial No. 76255557 · Reg. No. 2525104
Pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.